Cited by 652Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Meyer-Lindenberg, Andreas, Miletich, Robert S., Kohn, Philip D., Esposito, Giuseppe, Carson, Richard E., Quarantelli, Mario, Weinberger, Daniel R., Berman, Karen Faith·2002·Nature Neuroscience

DOI 10.1038/nn804

Open this paper in CoChat — free account

Abstract

Both dopaminergic neurotransmission and prefrontal cortex (PFC) function are known to be abnormal in schizophrenia. To test the hypothesis that these phenomena are related, we measured presynaptic dopaminergic function simultaneously with regional cerebral blood flow during the Wisconsin Card Sorting Test (WCST) and a control task in unmedicated schizophrenic subjects and matched controls. We show that the dopaminergic uptake constant Ki in the striatum was significantly higher for patients than for controls. Patients had significantly less WCST-related activation in PFC. The two parameters were strongly linked in patients, but not controls. The tight within-patient coupling of these values, with decreased PFC activation predicting exaggerated striatal 6-fluorodopa uptake, supports the hypothesis that prefrontal cortex dysfunction may lead to dopaminergic transmission abnormalities.

Integrity signals

Registry

Crossref · 10.1038/nn804

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citation
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Self-citation
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
MRI-PET Registration with Automated Algorithm
Woods, R. P., Mazziotta, J. C., & Cherry, A. S. R. (1993) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199307000-00004 · Cited by 1,636
Positron-emission tomography
Ollinger, J. M., & Fessler, J. A. (1997) · IEEE Signal Processing Magazine · doi:10.1109/79.560323 · Cited by 1,168
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020

Flagged first, then by citations

Show all 50 references

Research works printed but not linked: 1

Kraepelin, E., Barclay, R. M. & Robertson, G. M. Dementia Præcox and Paraphrenia (E. & S. Livingstone, Edinburgh, 1919).

Sorted by citations

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Addiction
Robinson, T. E., & Berridge, K. C. (2003) · Annual Review of Psychology · doi:10.1146/annurev.psych.54.101601.145237 · Cited by 1,509
Intermediate phenotypes and genetic mechanisms of psychiatric disorders
Meyer-Lindenberg, A., & Weinberger, D. R. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1993 · Cited by 1,216
Self-citation
Schizophrenia
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer‐Lindenberg, A., Weinberger, D. R., Cannon, T. D., O’Donovan, M. C., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,163
Self-citation
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment: Meta-analysis of Imaging Studies
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
van Os, J., Rutten, B. P., & Poulton, R. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn117 · Cited by 713
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
Intra-individual variability in behavior: links to brain structure, neurotransmission and neuronal activity
MacDonald, S. W. S., Nyberg, L., & Bäckman, L. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.06.011 · Cited by 664
The environment and susceptibility to schizophrenia
Brown, A. S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.003 · Cited by 664
Half a century of antipsychotics and still a central role for dopamine D2 receptors
Kapur, S., & Mamo, D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.004 · Cited by 638
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia
Winterer, G., & Weinberger, D. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.002 · Cited by 610
Self-citation
Dysfunction of ventral striatal reward prediction in schizophrenia
Juckel, G., Schlagenhauf, F., Koslowski, M., Wüstenberg, T., Villringer, A., Knutson, B., Wrase, J., & Heinz, A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.07.051 · Cited by 578
Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior
Goto, Y., & Grace, A. A. (2005) · Nature Neuroscience · doi:10.1038/nn1471 · Cited by 576
Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia
Meyer-Lindenberg, A. S., Olsen, R. K., Kohn, P. D., Brown, T., Egan, M. F., Weinberger, D. R., & Berman, K. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.379 · Cited by 574
Self-citation
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544
Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning
Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.023 · Cited by 520
Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms
Giuffrida, A., Leweke, F. M., Gerth, C. W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkötter, J., & Piomelli, D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300558 · Cited by 481
A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia
Simpson, E. H., Kellendonk, C., & Kandel, E. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.014 · Cited by 478
Disrupted prediction-error signal in psychosis: Evidence for an associative account of delusions
Corlett, P. R., Murray, G. K., Honey, G. D., Aitken, M. R. F., Shanks, D. R., Robbins, T. W., Bullmore, E. T., Dickinson, A., & Fletcher, P. C. (2007) · Brain · doi:10.1093/brain/awm173 · Cited by 460
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
The cognitive neuroscience of schizophrenia.
Barch, D. M. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143959 · Cited by 437
How similar are fluid cognition and general intelligence? A developmental neuroscience perspective on fluid cognition as an aspect of human cognitive ability
Blair, C. (2006) · Behavioral and Brain Sciences · doi:10.1017/s0140525x06009034 · Cited by 434
Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype
Meyer-Lindenberg, A., Kohn, P. D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., Weinberger, D. R., & Berman, K. F. (2005) · Nature Neuroscience · doi:10.1038/nn1438 · Cited by 428
Self-citation
Dopaminergic dysfunction in schizophrenia: Salience attribution revisited
Heinz, A., & Schlagenhauf, F. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq031 · Cited by 412
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 430
FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains
Lobo, M. K., Karsten, S. L., Gray, M., Geschwind, D. H., & Yang, X. W. (2006) · Nature Neuroscience · doi:10.1038/nn1654 · Cited by 411
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 421
Altered awareness of action in schizophrenia: a specific deficit in predicting action consequences
Voss, M., Moore, J., Hauser, M., Gallinat, J., Heinz, A., & Haggard, P. (2010) · Brain · doi:10.1093/brain/awq152 · Cited by 366
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Role of dopamine in the motivational and cognitive control of behavior
Cools, R. (2008) · The Neuroscientist · doi:10.1177/1073858408317009 · Cited by 352
Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
Keshavan, M. S., TANDON, R., Boutros, N. N., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.020 · Cited by 360
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010160 · Cited by 343
Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
Demjaha, A., Egerton, A., Murray, R. M., Kapur, S., Howes, O. D., Stone, J. M., & McGuire, P. K. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.011 · Cited by 347
Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia
Sarpal, D. K., Robinson, D. G., Lencz, T., Árgyelán, M., Ikuta, T., Karlsgodt, K. H., Gallego, J. A., Kane, J. M., Szeszko, P. R., & Malhotra, A. K. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1734 · Cited by 328
The effects of sleep deprivation on symptoms of psychopathology in healthy adults
Kahn-Greene, E. T., Killgore, D. B., Kamimori, G. H., Balkin, T. J., & Killgore, W. D. S. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.08.007 · Cited by 327
Selective Reinforcement Learning Deficits in Schizophrenia Support Predictions from Computational Models of Striatal-Cortical Dysfunction
Waltz, J. A., Frank, M. J., Robinson, B. M., & Gold, J. M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.042 · Cited by 326
Under the curve: Critical issues for elucidating D1 receptor function in working memory
Williams, G. V., & Castner, S. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.028 · Cited by 326
Catechol- O -Methyltransferase Genotype and Dopamine Regulation in the Human Brain
Akil, M., Kolachana, B. S., Rothmond, D. A., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02008.2003 · Cited by 325
Self-citation
From maps to mechanisms through neuroimaging of schizophrenia
Meyer‐Lindenberg, A. (2010) · Nature · doi:10.1038/nature09569 · Cited by 325
Self-citation
Defining the locus of dopaminergic dysfunction in schizophrenia: A meta-analysis and test of the mesolimbic hypothesis
McCutcheon, R., Beck, K., Jauhar, S., & Howes, O. D. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx180 · Cited by 305
Pathway-Specific Dopamine Abnormalities in Schizophrenia
Weinstein, J. J., Chohan, M. O., Slifstein, M., Kegeles, L. S., Moore, H. M., & Abi‐Dargham, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.03.2104 · Cited by 308
Functional Dysconnectivity of Corticostriatal Circuitry as a Risk Phenotype for Psychosis
Fornito, A., Harrison, B. J., Goodby, E., Dean, A., Ooi, C., Nathan, P. J., Lennox, B. R., Jones, P. B., Suckling, J., & Bullmore, E. T. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1976 · Cited by 279
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
Hanson, D. R., & Gottesman, I. I. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-7 · Cited by 274
Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene–environment interaction: objectives, sample characteristics, recruitment and assessment methods
Korver‐Nieberg, N., Quee, P. J., Boos, H. B. M., Simons, C. J. P., de Haan, L., & GROUP investigators (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1352 · Cited by 270
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
Tzavara, E. T., Davis, R. J., Perry, K. W., Li, X., Salhoff, C. R., Bymaster, F. P., Witkin, J. M., & Nomikos, G. G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705100 · Cited by 270
The traumagenic neurodevelopmental model of psychosis revisited
Read, J., Fosse, R., Moskowitz, A., & Perry, B. (2014) · Neuropsychiatry · doi:10.2217/npy.13.89 · Cited by 262
Unexpected expression of α- and β-globin in mesencephalic dopaminergic neurons and glial cells
Biagioli, M., Pinto, M., Cesselli, D., Zaninello, M., Lazarević, D., Roncaglia, P., Simone, R., Vlachouli, C., Plessy, C., Bertin, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813216106 · Cited by 261
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Fusar‐Poli, P., & Meyer‐Lindenberg, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr180 · Cited by 267
Self-citation
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Egerton, A., Chaddock, C. A., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Allen, P., McGuire, P. K., & Howes, O. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.017 · Cited by 253
From the Golgi–Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission
Fuxé, K., Dahlström, A. B., Höistad, M., Marcellino, D. J., Jansson, A., Rivera, A., Dı́az-Cabiale, Z., Jacobsen, K. R., Tinner, B., Hagman, B., et al. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.009 · Cited by 252
Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer
Tabarés-Seisdedos, R., & Rubenstein, J. L. R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.2 · Cited by 244
Executive Function, Neural Circuitry, and Genetic Mechanisms in Schizophrenia
Eisenberg, D. P., & Berman, K. F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.111 · Cited by 253
Self-citation
Dopamine hypothesis of schizophrenia: Making sense of it all
Toda, M., & Abi-Dargham, A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0041-7 · Cited by 235
Abnormal Frontostriatal Interactions in People With Prodromal Signs of Psychosis: A Multimodal Imaging Study
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Grasby, P. M., & McGuire, P. K. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.77 · Cited by 234
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
Jauhar, S., Nour, M. M., Veronese, M., Rogdaki, M., Bonoldi, I., Azis, M., Turkheimer, F., McGuire, P., Young, A. H., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2943 · Cited by 233
An Ultrasensitive Nanowire-Transistor Biosensor for Detecting Dopamine Release from Living PC12 Cells under Hypoxic Stimulation
Li, B., Hsieh, Y., Chen, Y., Chung, Y.-T., Pan, C., & Chen, Y. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408485m · Cited by 235
Age-related changes in midbrain dopaminergic regulation of the human reward system
Dreher, J.-C., Meyer-Lindenberg, A., Kohn, P., & Berman, K. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802127105 · Cited by 230
Self-citation
Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition
Meyer‐Lindenberg, A., Straub, R. E., Lipska, B. K., Verchinski, B. A., Goldberg, T. E., Callicott, J. H., Egan, M. F., Huffaker, S., Mattay, V. S., Kolachana, B. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30413 · Cited by 228
Self-citation
Presynaptic Dopaminergic Dysfunction in Schizophrenia
McGowan, S., Lawrence, A. D., Sales, T., Quested, D. J., & Grasby, P. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.2.134 · Cited by 229
Do you know the sex of your cells?
Shah, K., McCormack, C. E., & Bradbury, N. A. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00281.2013 · Cited by 219
Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients
Nielsen, M. Ø., Rostrup, E., Wulff, S., Bak, N. K., Lublin, H., Kapur, S., & Glenthoj, B. Y. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.007 · Cited by 224
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects
Abi-Dargham, A., van de Giessen, E., Slifstein, M., Kegeles, L. S., & Laruelle, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.007 · Cited by 213
Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment
Sarpal, D. K., Argyelan, M., Robinson, D. G., Szeszko, P. R., Karlsgodt, K. H., John, M., Weissman, N., Gallego, J. A., Kane, J. M., Lencz, T., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14121571 · Cited by 212
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder
Lanz, T. A., Reinhart, V., Sheehan, M. J., Rizzo, S. J. S., Bove, S. E., James, L. C., Volfson, D., Lewis, D. A., & Kleiman, R. J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0492-8 · Cited by 215
Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Montgomery, A. J., Grasby, P. M., & McGuire, P. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.108 · Cited by 207
Neurotransmitters and prefrontal cortex–limbic system interactions: implications for plasticity and psychiatric disorders
Arco, A. D., & Mora, F. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0243-8 · Cited by 211
Midbrain dopamine function in schizophrenia and depression: A post-mortem and positron emission tomographic imaging study
Howes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain · doi:10.1093/brain/awt264 · Cited by 198
Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia
Rajkowska, G., Miguel-Hidalgo, J. J., Makkos, Z., Meltzer, H. Y., Overholser, J. C., & Stockmeier, C. A. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00339-0 · Cited by 196
Awareness of action in schizophrenia
Haggard, P., Martin, F., Taylor-Clarke, M., Jeannerod, M., & Nicolas Franck, B. (2003) · Neuroreport · doi:10.1097/01.wnr.0000073684.00308.c0 · Cited by 194
Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain
Sinclair, D., Purves-Tyson, T. D., Allen, K. M., & Weickert, C. S. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3415-z · Cited by 191
Midbrain dopaminergic neurons: A review of the molecular circuitry that regulates their development
Hegarty, S. V., Sullivan, A. M., & O’Keeffe, G. W. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.04.014 · Cited by 190
Weakened center-surround interactions in visual motion processing in schizophrenia
Tadin, D., Kim, J., Doop, M. L., Gibson, C., Lappin, J. S., Blake, R., & Park, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2592-06.2006 · Cited by 182
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies
Abi-Dargham, A., & Laruelle, M. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.11.003 · Cited by 179
Calcium signaling dysfunction in schizophrenia: a unifying approach
Lidow, M. S. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00203-0 · Cited by 174
Regulation of conditioned responses of basolateral amygdala neurons
GRACE, A., & ROSENKRANZ, J. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00909-5 · Cited by 172
Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance
van Rossum, I., Dominguez, M.-D.-G., Lieb, R., Wittchen, H.-U., & van Os, J. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp101 · Cited by 170
Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis
Huang, J. T.-J., Leweke, F. M., Oxley, D., Wang, L., Harris, N., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030428 · Cited by 169
Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility
Murray, A., Wołoszynowska-Fraser, M. U., Ansel-Bollepalli, L., Marshall-Phelps, K. L., Foggetti, A., Crouch, B., Riedel, G., & Wulff, P. (2015) · Scientific Reports · doi:10.1038/srep16778 · Cited by 173
Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex
Del Arco, A., & Mora, F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.011 · Cited by 163
Increased Caudate Dopamine D2 Receptor Availability as a Genetic Marker for Schizophrenia
Hirvonen, J., van Erp, T. G. M., Huttunen, J., Aalto, S., Någren, K., HUTTUNEN, M. O., Lönnqvist, J. K., Kaprio, J. A., Hietala, J. A., & Cannon, T. D. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.371 · Cited by 161
Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis
Dandash, O., Fornito, A., Lee, J., Keefe, R. S. E., Chee, M. W. L., Adcock, R. A., Pantelis, C., Wood, S. J., & Harrison, B. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt093 · Cited by 165
Self-Representation in Nervous Systems.
Churchland, P. S. (2002) · Science · doi:10.1126/science.1070564 · Cited by 160
Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes
Tost, H., Alam, T., & Meyer-Lindenberg, A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.005 · Cited by 160
Self-citation
Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study
Kumakura, Y., Cumming, P. D., Vernaleken, I., Buchholz, H., Siessmeier, T., Heinz, A., Kienast, T., Bartenstein, P., & Gründer, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0805-07.2007 · Cited by 158
Functional neuroimaging in schizophrenia: diagnosis and drug discovery
McGuire, P. K., Howes, O. D., Stone, J. M., & Fusar‐Poli, P. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.005 · Cited by 157
Cognitive impairments in psychotic disorders: common mechanisms and measurement
Barch, D. M., & Sheffield, J. M. (2014) · World Psychiatry · doi:10.1002/wps.20145 · Cited by 154
[123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease
Lorberboym, M., Treves, T. A., Melamed, E., Lampl, Y., Hellmann, M. A., & Djaldetti, R. (2005) · Movement Disorders · doi:10.1002/mds.20748 · Cited by 154
Molecular basis for catecholaminergic neuron diversity
Grimm, J., Mueller, A., Hefti, F., & Rosenthal, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405340101 · Cited by 150
Stress-Induced Dopamine Release in Humans at Risk of Psychosis: a [11C]Raclopride PET Study
Soliman, A., O'Driscoll, G., Pruessner, J., Holahan, A., Boileau, I., Gagnon, D., & Dagher, A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301597 · Cited by 156
When Desire Collides with Reason: Functional Interactions between Anteroventral Prefrontal Cortex and Nucleus Accumbens Underlie the Human Ability to Resist Impulsive Desires
Diekhof, E. K., & Gruber, O. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4690-09.2010 · Cited by 150
Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis
Suzuki, M., Zhou, S.-Y., Takahashi, T., Hagino, H., Kawasaki, Y., Niu, L., Matsui, M., Seto, H., & Kurachi, M. (2005) · Brain · doi:10.1093/brain/awh554 · Cited by 150
Mechanism of action of antipsychotic drugs: From dopamine D2 receptor antagonism to glutamate NMDA facilitation
Laruelle, M. A., Frankle, W. G., Narendran, R., Kegeles, L. S., & Abi‐Dargham, A. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.07.017 · Cited by 150
Impaired Prefrontal-Basal Ganglia Functional Connectivity and Substantia Nigra Hyperactivity in Schizophrenia
Yoon, J. H., Minzenberg, M., Raouf, S., D’Esposito, M., & Carter, C. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.018 · Cited by 146
Social norms, self-control, and the value of antisocial behavior
Buckholtz, J. W. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.03.004 · Cited by 154
Chemistry of the Adaptive Mind: Lessons from Dopamine
Cools, R. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.035 · Cited by 150
Polypharmacy in schizophrenia
Zink, M., Englisch, S., & Meyer‐Lindenberg, A. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283366427 · Cited by 143
Self-citation
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
Howes, O. D., Montgomery, A. J., Asselin, M., Murray, R. M., Grasby, P. M., & McGuire, P. K. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.51.s13 · Cited by 144
Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder
Reinhart, V., Bove, S. E., Volfson, D., Lewis, D. A., Kleiman, R. J., & Lanz, T. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.011 · Cited by 143

Authors: Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F.
Affiliations: National Institutes of Health (US)
ORCID: Carson, Richard E.
Quarantelli, Mario
Weinberger, Daniel R.
Berman, Karen Faith
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2002-01-28
Volume: 5
Issue: 3
Pages: 267-271
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn804
OpenAlex: W2004729128
Cited by: 652
References: 50
Citations by year: 2026: 8 · 2025: 14 · 2024: 13 · 2023: 9 · 2022: 15 · 2021: 30 · 2020: 16 · 2019: 32 · 2018: 20 · 2017: 25 · 2016: 31 · 2015: 41 · 2014: 35 · 2013: 38 · 2012: 40
FWCI: 19.67
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords: schizophrenia, prefrontal cortex, striatum, dopamine signaling, dopamine uptake, regional cerebral blood flow, Wisconsin Card Sorting Test, prefrontal cortex activation
MeSH terms: Cerebrovascular Circulation, Corpus Striatum, Dihydroxyphenylalanine, Dopamine, Fluorine Radioisotopes, Humans, Neuropsychological Tests, Schizophrenia, Statistics as Topic, Synapses, Tomography, Emission-Computed, Prefrontal Cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks